Treatment of Thrombocytopenia secondary to chemotherapy – MCQ

Which of the following agents is used for the treatment of Thrombocytopenia secondary to myelosuppressive cancer chemotherapy?
A. Filgrastim
B. Sargramostim
C. Oprelvekin
D. Erythropoietin

Correct answer : C. Oprelvekin

  • Oprelvekin (Interleukin 11) is the only agent approved by the FDA for treatment of thrombocytopenia secondary to myelosuppressive cancer chemotherapy
  • Filgrastim (G-CSF) and Sargramostim (GM-SCF) are used in the treatment of neutropenia
  • Erythropoietin is used in treatment of anemia

Add a Comment

Your email address will not be published. Comments will be displayed only after moderation.

Read previous post:
pharmacology mcq
Aprepitant – MCQ

All of the following statements about Aprepitant are true except? A. Agonist at Neurokinin receptor (NK1) B. Crosses blood brain barrier...